Plasma levels of the inflammatory cytokine IL-6 were measured in a sub-group (n = 30) of placebo-treated TB patients and demonstrated significantly higher (p < 0.0001) IL-6 levels in patients with active TB compared to healthy controls (Figure 5A). The gene discussed is IL6; the disease is tuberculosis.